Evolus Inc
Evolus Inc (EOLS) Implied Volatility Current
EOLS's 30 day implied volatility is 95.93%, with an IV Rank of 44.05%. This is an average IV Rank versus the past year, meaning Evolus Inc options are fairly priced and currently offer no clear edge to buyers or sellers. EOLS's 30 day historical volatility sits at 60.64%, which means implied volatility is running 35.29 points above historical volatility, as of Nov 17, 2026.
Read more
Tracking EOLS implied volatility helps you spot when Evolus Inc options are historically cheap or expensive, and where the best trades are hiding. When EOLS IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor EOLS implied volatility current levels in real time and filter for high probability trades.
Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking EOLS IV rank helps you see whether EOLS's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Implied Volatility
IV is slightly elevated. Premiums are richer, leaning toward sellers.
As of Nov 17, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →